Published in Nat Microbiol on August 08, 2016
The HIV-1 envelope glycoprotein structure: nailing down a moving target. Immunol Rev (2017) 0.79
Risks Posed by Reston, the Forgotten Ebolavirus. mSphere (2016) 0.75
Fighting Ebola: A Window for Vaccine Re-evaluation? PLoS Pathog (2017) 0.75
Overexpression of Ebola virus envelope GP1 protein. Protein Expr Purif (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2009) 53.36
Accurate determination of local defocus and specimen tilt in electron microscopy. J Struct Biol (2003) 14.19
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science (2014) 12.99
RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol (2012) 10.13
Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM. Nat Methods (2013) 8.12
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet (2015) 8.12
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature (2014) 6.94
Prevention of overfitting in cryo-EM structure determination. Nat Methods (2012) 5.65
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature (2008) 5.24
Epitopes involved in antibody-mediated protection from Ebola virus. Science (2000) 4.92
DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. J Struct Biol (2009) 3.71
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med (2012) 2.98
Refinement of protein structures into low-resolution density maps using rosetta. J Mol Biol (2009) 2.94
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A (2012) 2.83
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog (2007) 2.64
Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J Infect Dis (2011) 2.30
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nat Med (2014) 2.09
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep (2013) 2.01
GlyProt: in silico glycosylation of proteins. Nucleic Acids Res (2005) 1.97
Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB. Nucleic Acids Res (2005) 1.84
A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol (2011) 1.84
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proc Natl Acad Sci U S A (2011) 1.80
Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin Immunol (2011) 1.73
The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology (1998) 1.62
Type I and type II Fc receptors regulate innate and adaptive immunity. Nat Immunol (2014) 1.58
Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins (2009) 1.57
Ebolavirus glycoprotein structure and mechanism of entry. Future Virol (2009) 1.56
Atomic-accuracy models from 4.5-Å cryo-electron microscopy data with density-guided iterative local refinement. Nat Methods (2015) 1.52
Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE). PLoS One (2013) 1.49
Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J Virol (2011) 1.46
Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia. Emerg Infect Dis (2015) 1.45
Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc Natl Acad Sci U S A (2014) 1.44
Fabs enable single particle cryoEM studies of small proteins. Structure (2012) 1.25
Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus. Sci Rep (2014) 1.24
Privateer: software for the conformational validation of carbohydrate structures. Nat Struct Mol Biol (2015) 1.07
EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat Methods (2015) 1.07
Mechanism of human antibody-mediated neutralization of Marburg virus. Cell (2015) 1.04
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell (2016) 1.02
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies. J Virol (2015) 1.00
Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein. Acta Crystallogr D Biol Crystallogr (2009) 0.99
The multiple roles of sGP in Ebola pathogenesis. Viral Immunol (2015) 0.98
Disulfide bond assignment of the Ebola virus secreted glycoprotein SGP. Biochem Biophys Res Commun (2004) 0.97
Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science (2016) 0.92
Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies. MBio (2016) 0.88
Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry. J Virol (2016) 0.81
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability. Nat Microbiol (2016) 0.82
Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Sci Transl Med (2017) 0.76